MRNA — Moderna, Inc. — Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

MRNA

Moderna, Inc.

$53.54

+1.84 (+4.29%)

Data provided by Interactive Brokers. Prices may be delayed.

Price Chart

Articles (2)

Mar 10, 2026 Europe BioNTech Leadership Change: -17.9% Crash After Billion-Euro Loss Mar 4, 2026 Pharma & Healthcare Moderna Patent Settlement +11.3% Surge: Is the $2.25B Hit Worth the Clarity?

All Articles about Moderna, Inc.

Europe

BioNTech Leadership Change: -17.9% Crash After Billion-Euro Loss

Can BioNTech’s surprise leadership change and deepening losses turn a Covid-era star into a long-term oncology value play or a value trap? How did markets…

Mar 10, 2026

Pharma & Healthcare

Moderna Patent Settlement +11.3% Surge: Is the $2.25B Hit Worth the Clarity?

Does Moderna’s billion‑dollar patent peace deal finally clear the runway for its mRNA pipeline—or just cap the upside? Moderna Patent Settlement: Why Wall Street Is…

Mar 4, 2026

News Feed

Real-time news feed for MRNA is coming soon.
Check back for live market news and analyst updates.